TipRanks
Go Ultimate55% OFF

Genmab (GE91) Revenue

Genmab Revenue

Genmab had a revenue of 1.16B in the quarter ending Jun 30, 2026, with 28.43%. This bring the company's revenue in the last twelve months to 4.13B, Increased 5.90%. In the fiscal year ending Dec 31, 2025, Genmab had annual revenue of 3.72B with -82.70% growth.

Revenue (ttm)
4.13B
Revenue Growth
14.22%
P/S Ratio
8.37
Revenue/Employee
EUR 1,193,631
Employees
3,119
Market Cap
EUR 31.15B

Revenue Chart

Genmab Revenue - Annual

05B10B15B20B25B2.37B3.03B5.37B10.11B8.42B14.51B16.47B21.53B3.72B201720182019202020212022202320242025
Revenue History
Download to Excel
DE:GE91 revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20253.72B-17.80B-82.70%
Dec 31, 202421.53B5.05B30.67%
Dec 31, 202316.47B1.97B13.57%
Dec 31, 202214.51B6.09B72.33%
Dec 31, 20218.42B-1.69B-16.75%
Dec 31, 202010.11B4.75B88.43%
Dec 31, 20195.37B2.34B77.38%
Dec 31, 20183.03B659.70M27.89%
Dec 31, 20172.37B――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:GE914.13B
XNCR104.97M
TGTX799.54M
ZYME37.13M
BNTX2.64B
LEGN1.27B